Balchem Co. (NASDAQ:BCPC – Get Rating) hit a new 52-week low during trading on Tuesday . The stock traded as low as $110.15 and last traded at $116.67, with a volume of 150857 shares trading hands. The stock had previously closed at $114.59.
A number of research firms have weighed in on BCPC. StockNews.com began coverage on Balchem in a research note on Thursday, March 31st. They issued a “buy” rating for the company. HC Wainwright decreased their target price on shares of Balchem from $155.00 to $152.00 and set a “buy” rating for the company in a research note on Monday, May 2nd.
The firm has a market cap of $3.79 billion, a price-to-earnings ratio of 37.81 and a beta of 0.66. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.71 and a current ratio of 2.59. The firm has a fifty day simple moving average of $123.07 and a 200-day simple moving average of $138.99.
Institutional investors and hedge funds have recently modified their holdings of the company. Intelligent Financial Strategies acquired a new position in Balchem in the 4th quarter worth about $25,000. CWM LLC acquired a new stake in Balchem in the fourth quarter valued at $28,000. Quantbot Technologies LP bought a new position in Balchem during the 1st quarter worth $34,000. Captrust Financial Advisors lifted its holdings in Balchem by 195.4% during the 3rd quarter. Captrust Financial Advisors now owns 319 shares of the basic materials company’s stock worth $46,000 after buying an additional 211 shares during the period. Finally, UMB Bank N A MO bought a new stake in shares of Balchem in the 4th quarter valued at about $56,000. Institutional investors own 89.60% of the company’s stock.
Balchem Company Profile (NASDAQ:BCPC)
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
- Get a free copy of the StockNews.com research report on Balchem (BCPC)
- Victoria’s Secret Stock is Out of the Box
- Downturn Gives These 3 Buys Juicy Dividend Yields
- Time For a Ride in Six Flags Stock
- Why Dollar General (NYSE: DG) Should Be In Your Portfolio
- Korn Ferry Is A Good Buy For The Recession And Beyond
Receive News & Ratings for Balchem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Balchem and related companies with MarketBeat.com's FREE daily email newsletter.